DPP-4 inhibitor anagliptin protects against hypoxia-induced cytotoxicity in cardiac H9C2 cells

Cardiovascular complications are the leading cause of mortality and morbidity in type 2 diabetes patients. Diabetes greatly increases the risk of heart disease; therefore, the management of diabetes often involves the prevention of heart disease. DPP-4 inhibitors have been proven to be the effective...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Yunxiang Ma, Junkai Wang, Changhua Wang, Qiong Zhang, Yannan Xu, Huajin Liu, Xia Xiang, Jiangwei Ma
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis Group 2019-12-01
Reeks:Artificial Cells, Nanomedicine, and Biotechnology
Onderwerpen:
DPP-4
anagliptin
H9C2 cells
cardiomyocyte protection
Online toegang:https://www.tandfonline.com/doi/10.1080/21691401.2019.1652624
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
Wordt geladen...

Gelijkaardige items